Capsaicin 8% cutaneous patch: A promising treatment for brachioradial pruritus?

British Journal of Dermatology

Volumn 172, Issue 6, 2015, Pages 1669-1671

  Zeidler, C ^a   Luling H ^a   Dieckhofer A ^a   Osada, N ^a   Schedel, F ^a   Steinke, S ^a   Augustin, M ^b   Stander S ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; LIDOCAINE; ANTIPRURITIC AGENT;

ADULT; AGED; APPLICATION SITE BURNING; BRACHIORADIAL PRURITUS; CLINICAL ARTICLE; DENSITY; DERMATOLOGY LIFE QUALITY INDEX; DERMATOME; FEMALE; HUMAN; LETTER; MALE; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN INTENSITY; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; SKIN EXAMINATION; TRANSDERMAL PATCH; TREATMENT DURATION; VISUAL ANALOG SCALE; CUTANEOUS DRUG ADMINISTRATION; FOREARM; MIDDLE AGED; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; ANTIPRURITICS; CAPSAICIN; FEMALE; FOREARM; HUMANS; MIDDLE AGED; PRURITUS; QUALITY OF LIFE; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 84930381488     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13501     Document Type: Letter

References (15)

1. Stumpf A, Ständer S,. Neuropathic itch: diagnosis and management. Dermatol Ther 2013; 26: 104-9.
2. Marziniak M, Phan NQ, Raap U, et al,. Brachioradial pruritus as a result of cervical spine pathology: the results of a magnetic resonance tomography study. J Am Acad Dermatol 2011; 65: 756-62.
3. Masuda PY, Martelli ACC, Wachholz PA, et al,. Brachioradial pruritus-descriptive analysis of Brazilian case series. J Dtsch Dermatol Ges 2013; 11: 530-5.
4. Mirzoyev SA, Davis MD,. Brachioradial pruritus: Mayo Clinic experience over the past decade. Br J Dermatol 2013; 169: 1007-15.
5. Wallengren J, Sundler F,. Brachioradial pruritus is associated with a reduction in cutaneous innervation that normalizes during the symptom-free remissions. J Am Acad Dermatol 2005; 52: 142-5.
6. Schuhknecht B, Marziniak M, Wissel A, et al,. Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy. Br J Dermatol 2011; 165: 85-91.
7. Peppin JF, Pappagallo M,. Capsaicinoids in the treatment of neuropathic pain: a review. Ther Adv Neurol Disord 2014; 7: 22-32.
8. Kim YS, Chu Y, Han L, et al,. Central terminal sensitization of TRPV1 by descending serotonergic facilitation modulates chronic pain. Neuron 2014; 81: 873-87.
9. Cobzaru A,. High-concentration capsaicin patch (qutenza)-a new step in treatment of neuropathic pain. Maedica (Buchar) 2012; 7: 88-9.
10. Simpson DM, Gazda S, Brown S, et al,. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain. J Pain Symptom Manage 2010; 39: 1053-64.
11. Backonja MM, Malan TP, Vanhove GF, Tobias JK,. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension. Pain Med 2010; 11: 600-8.
12. ® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database. Pain 2013; 154: 1632-9.
13. Simone DA, Nolano M, Johnson T, et al,. Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci 1998; 18: 8947-59.
14. O'Neill J, Brock C, Olesen AE, et al,. Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev 2012; 64: 939-71.
15. Hardy J, Uthurriague C, Bibas N, et al,. Brachioradial pruritus revealing cervicomedullary astrocytoma and treated with 8% capsaicin patches. Ann Dermatol Venereol 2014; 141: 374-5.